Tags

Type your tag names separated by a space and hit enter

[Antiinfluenza-drugs and the standard of the use].
Nihon Rinsho. 2000 Nov; 58(11):2283-7.NR

Abstract

Amantadine is only effective for influenza A, but zanamivir and oseltamivir, neuramidase inhibitors are strongly effective for influenza A and B. At this time we are available for amantadine and zanamivir for influenza in Japan. Oseltamivir is now under investigation in Japan. In USA both new drugs have been approved by USA government. Influenza vaccine is the first line drug for prevention of influenza A and B. In cases influenza infection occurs, we should promptly select and give antiinfluenza drug for these patients during almost 5 days, considering renal condition. And we should keep in mind that these antiviral substances are not directly effective for inflammatory phenomenons which introduce the reduction of lung function. So we should use both therapies which include antiviral chemotherapy and serious rescue treatment for respiratory failure.

Authors+Show Affiliations

Ainomemorial Hospital.

Pub Type(s)

English Abstract
Journal Article
Review

Language

jpn

PubMed ID

11225318

Citation

Matsumoto, K. "[Antiinfluenza-drugs and the Standard of the Use]." Nihon Rinsho. Japanese Journal of Clinical Medicine, vol. 58, no. 11, 2000, pp. 2283-7.
Matsumoto K. [Antiinfluenza-drugs and the standard of the use]. Nihon Rinsho. 2000;58(11):2283-7.
Matsumoto, K. (2000). [Antiinfluenza-drugs and the standard of the use]. Nihon Rinsho. Japanese Journal of Clinical Medicine, 58(11), 2283-7.
Matsumoto K. [Antiinfluenza-drugs and the Standard of the Use]. Nihon Rinsho. 2000;58(11):2283-7. PubMed PMID: 11225318.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Antiinfluenza-drugs and the standard of the use]. A1 - Matsumoto,K, PY - 2001/2/28/pubmed PY - 2001/5/22/medline PY - 2001/2/28/entrez SP - 2283 EP - 7 JF - Nihon rinsho. Japanese journal of clinical medicine JO - Nihon Rinsho VL - 58 IS - 11 N2 - Amantadine is only effective for influenza A, but zanamivir and oseltamivir, neuramidase inhibitors are strongly effective for influenza A and B. At this time we are available for amantadine and zanamivir for influenza in Japan. Oseltamivir is now under investigation in Japan. In USA both new drugs have been approved by USA government. Influenza vaccine is the first line drug for prevention of influenza A and B. In cases influenza infection occurs, we should promptly select and give antiinfluenza drug for these patients during almost 5 days, considering renal condition. And we should keep in mind that these antiviral substances are not directly effective for inflammatory phenomenons which introduce the reduction of lung function. So we should use both therapies which include antiviral chemotherapy and serious rescue treatment for respiratory failure. SN - 0047-1852 UR - https://www.unboundmedicine.com/medline/citation/11225318/[Antiinfluenza_drugs_and_the_standard_of_the_use]_ L2 - https://medlineplus.gov/flu.html DB - PRIME DP - Unbound Medicine ER -